Published in Diabetes Educ on August 20, 2010
Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care (2005) 5.38
Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the Structured Testing Program study. Diabetes Care (2011) 4.30
Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care (2005) 3.77
Is self-efficacy associated with diabetes self-management across race/ethnicity and health literacy? Diabetes Care (2006) 3.22
Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med (2011) 3.21
Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long). Diabetes Care (2012) 2.89
Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract (2007) 1.88
Significant insulin dose errors may occur if blood glucose results are obtained from miscoded meters. J Diabetes Sci Technol (2007) 1.83
Serum 1,5-anhydroglucitol (GlycoMark ): a short-term glycemic marker. Diabetes Technol Ther (2003) 1.74
Predictors of glycemic control among patients with Type 2 diabetes: a longitudinal study. BMC Public Health (2005) 1.60
Improved glucose excursions using an implantable real-time continuous glucose sensor in adults with type 1 diabetes. Diabetes Care (2004) 1.60
Management of cluster headache. Am Fam Physician (2005) 1.58
The association of vitamin D status with pediatric critical illness. Pediatrics (2012) 1.53
Depression in diabetes: have we been missing something important? Diabetes Care (2011) 1.51
Cost-effectiveness of diabetes case management for low-income populations. Health Serv Res (2007) 1.51
Self-monitoring of blood glucose in noninsulin-using type 2 diabetic patients: right answer, but wrong question: self-monitoring of blood glucose can be clinically valuable for noninsulin users. Diabetes Care (2013) 1.45
A structured self-monitoring of blood glucose approach in type 2 diabetes encourages more frequent, intensive, and effective physician interventions: results from the STeP study. Diabetes Technol Ther (2011) 1.38
Outcomes of Project Dulce: a culturally specific diabetes management program. Ann Pharmacother (2005) 1.37
The value of episodic, intensive blood glucose monitoring in non-insulin treated persons with Type 2 Diabetes: design of the Structured Testing Program (STeP) study, a cluster-randomised, clinical trial [NCT00674986]. BMC Fam Pract (2010) 1.30
Family and disease management in African-American patients with type 2 diabetes. Diabetes Care (2004) 1.22
United States patient preference and usability for the new disposable insulin device Solostar versus other disposable pens. J Diabetes Sci Technol (2008) 1.20
Daily negative mood affects fasting glucose in type 2 diabetes. Health Psychol (2009) 1.18
Gender differences in long-term posttraumatic stress disorder outcomes after major trauma: women are at higher risk of adverse outcomes than men. J Trauma (2002) 1.17
Reductions in regimen distress are associated with improved management and glycemic control over time. Diabetes Care (2013) 1.14
Comparison of measured utility scores and imputed scores from the SF-36 in patients with rheumatoid arthritis. Med Care (2005) 1.14
Problem solving and diabetes self-management: investigation in a large, multiracial sample. Diabetes Care (2007) 1.12
Improving treatment of depression among Latinos with diabetes using project Dulce and IMPACT. Diabetes Care (2008) 1.08
Type 2 diabetes care and insulin intensification: is a more multidisciplinary approach needed? Results from the MODIFY survey. Diabetes Educ (2010) 1.07
A survey of blood glucose monitoring in patients with type 2 diabetes: are recommendations from health care professionals being followed? Curr Med Res Opin (2011) 1.06
Family predictors of disease management over one year in Latino and European American patients with type 2 diabetes. Fam Process (2003) 1.03
Patients with type 2 diabetes at risk for major depressive disorder over time. Ann Fam Med (2011) 1.02
Patient age: a neglected factor when considering disease management in adults with type 2 diabetes. Patient Educ Couns (2010) 1.01
Use of RE-AIM to develop a multi-media facilitation tool for the patient-centered medical home. Implement Sci (2011) 1.01
Practice facilitation to improve diabetes care in primary care: a report from the EPIC randomized clinical trial. Ann Fam Med (2014) 1.00
Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol (2004) 0.98
A call for more effectively integrating behavioral and social science principles into comprehensive diabetes care. Diabetes Care (2007) 0.97
Mental health treatment preferences of older and younger primary care patients. Int J Psychiatry Med (2004) 0.96
Gastrointestinal complications of diabetes. Endocrinol Metab Clin North Am (2013) 0.95
BIOSIMILARS AND NEW INSULIN VERSIONS. Endocr Pract (2015) 0.95
HOW PATIENTS WITH TYPE 1 DIABETES TRANSLATE CONTINUOUS GLUCOSE MONITORING DATA INTO DIABETES MANAGEMENT DECISIONS. Endocr Pract (2015) 0.94
The first three years of screening for medium chain acyl-CoA dehydrogenase deficiency (MCADD) by newborn screening ontario. BMC Pediatr (2010) 0.93
Ethnic differences in complementary and alternative medicine use among patients with diabetes. Complement Ther Med (2010) 0.92
Use of a website to accomplish health behavior change: if you build it, will they come? And will it work if they do? J Am Board Fam Med (2013) 0.91
Use of the quality of well-being self-administered version (QWB-SA) in assessing health-related quality of life in depressed patients. J Affect Disord (2003) 0.91
Osteoporosis and diabetes. Curr Diab Rep (2003) 0.88
A digital microfluidic method for dried blood spot analysis. Lab Chip (2011) 0.87
Glycemic control among Latinos with type 2 diabetes: the role of social-environmental support resources. Health Psychol (2011) 0.87
Predictors of dropouts from a San Diego diabetes program: a case control study. Prev Chronic Dis (2004) 0.87
Outcomes from a culturally tailored diabetes prevention program in Hispanic families from a low-income school: Horton Hawks Stay Healthy (HHSH). Diabetes Educ (2010) 0.86
The incretin effect and its potentiation by glucagon-like peptide 1-based therapies: a revolution in diabetes management. Expert Opin Investig Drugs (2005) 0.86
Changes in A1C levels are significantly associated with changes in levels of the cardiovascular risk biomarker hs-CRP: results from the SteP study. Diabetes Care (2013) 0.86
Gastrointestinal disturbances in diabetes. Curr Diab Rep (2003) 0.86
A Mobile Health Intervention Supporting Heart Failure Patients and Their Informal Caregivers: A Randomized Comparative Effectiveness Trial. J Med Internet Res (2015) 0.85
Using multiple measures of glycemia to support individualized diabetes management: recommendations for clinicians, patients, and payers. Diabetes Technol Ther (2012) 0.85
Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetes. J Clin Endocrinol Metab (2004) 0.85
High-throughput and simultaneous measurement of homocysteine and cysteine in human plasma and urine by liquid chromatography-electrospray tandem mass spectrometry. Anal Biochem (2007) 0.85
Pharmacokinetics and glucodynamics of rapid-, short-, and intermediate-acting insulins: comparison of jet injection to needle syringe. Diabetes Technol Ther (2002) 0.84
Primary care medical provider attitudes regarding mental health and behavioral medicine in integrated and non-integrated primary care practice settings. J Clin Psychol Med Settings (2012) 0.83
Pramlintide as an adjunct to insulin in patients with type 2 diabetes in a clinical practice setting reduced A1C, postprandial glucose excursions, and weight. Diabetes Technol Ther (2007) 0.82
A community-based program to encourage patients' attention to their own diabetes care: pilot development and evaluation. Diabetes Educ (2005) 0.81
Validity of self-administered quality of well-being scale in musculoskeletal disease. Arthritis Rheum (2004) 0.81
Erectile dysfunction and diabetes. Curr Diab Rep (2002) 0.81
Pramlintide improved measures of glycemic control and body weight in patients with type 1 diabetes mellitus undergoing continuous subcutaneous insulin infusion therapy. Postgrad Med (2013) 0.81
Aspects of culturally competent care are associated with less emotional burden among patients with diabetes. Med Care (2012) 0.81
Insulin therapy in type 2 diabetes. Med Clin North Am (2004) 0.81
Incretins and their role in the management of diabetes. Curr Opin Endocrinol Diabetes Obes (2007) 0.80
Impact of anesthesia and surgery for congenital heart disease on the vitamin d status of infants and children: a prospective longitudinal study. Anesthesiology (2013) 0.80
When does personalized feedback make a difference? A narrative review of recent findings and their implications for promoting better diabetes self-care. Curr Diab Rep (2015) 0.79
Support for disease management, depression, self-care, and clinical indicators among Hispanics with type 2 diabetes in San Diego County, United States of America. Rev Panam Salud Publica (2010) 0.79
Practice context affects efforts to improve diabetes care for primary care patients: a pragmatic cluster randomized trial. J Gen Intern Med (2014) 0.79
Development and validation of a mental health subscale from the Quality of Well-Being Self-Administered. Qual Life Res (2012) 0.78
A 16-week open-label, multicenter pilot study assessing insulin pump therapy in patients with type 2 diabetes suboptimally controlled with multiple daily injections. J Diabetes Sci Technol (2011) 0.78
Insulin pen use for type 2 diabetes--a clinical perspective. Diabetes Technol Ther (2010) 0.78
Building a pipeline of training for behavioral diabetes researchers and clinicians: a call for national dialogue. Curr Diab Rep (2011) 0.77
Age and glycemic control among low-income Latinos. J Immigr Minor Health (2013) 0.77
Young adult African American patients with type 2 diabetes: a high risk patient sub-group with few supports for good diabetes management. J Health Psychol (2011) 0.77
Measurement of homocysteine and related metabolites in human plasma and urine by liquid chromatography electrospray tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.77
A new option for glycemic control: insulin degludec, a new-generation basal insulin with an ultralong duration of action. Pharmacotherapy (2013) 0.77
Short-term effects of nocturnal haemodialysis on carnitine metabolism. Nephrol Dial Transplant (2006) 0.76
Patient perspectives on the role of weight management in type 2 diabetes. Diabetes Res Clin Pract (2010) 0.76
Diagnosis of glutaric aciduria type 1 by measuring 3-hydroxyglutaric acid in dried urine spots by liquid chromatography tandem mass spectrometry. J Inherit Metab Dis (2010) 0.76
New technologies to advance self-management support in diabetes: not just a bunch of cool apps! Diabetes Care (2011) 0.75
Pramlintide as an adjunct to insulin therapy. Curr Diab Rep (2003) 0.75
Thiazolidinediones. N Engl J Med (2005) 0.75
Insulin pump therapy versus multiple daily injections. Curr Diab Rep (2002) 0.75
BNP levels to screen for left ventricular dysfunction. Curr Diab Rep (2004) 0.75
Insulin-pump therapy for type 1 diabetes mellitus. N Engl J Med (2012) 0.75
Testing versus guessing blood glucose values: impact on self-care behaviors in type 2 diabetes. Curr Med Res Opin (2014) 0.75
Teen peer educators and diabetes knowledge of low-income fifth grade students. J Community Health (2011) 0.75
Through the looking glass: current and future perspectives on the role of hormonal interplay in glucose homeostasis. Diabetes Educ (2007) 0.75
Quantification of DNA in neonatal dried blood spots by adenine tandem mass spectrometry. Anal Chem (2017) 0.75
Hypoglycemia unawareness and type 1 diabetes. South Med J (2004) 0.75
Pumps and type 2 diabetes. If you can improve your diabetes control, and if you can accommodate yourself to it, the pump might just be the best diabetes therapy for you. Diabetes Forecast (2002) 0.75
The role of self-monitoring of blood glucose during the treatment of type 2 diabetes with medications targeting postprandial hyperglycemia. South Med J (2007) 0.75